CAITLIN MATHISON: Open Payments
NPI 1194152553 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,371 in 64 payments from 19 companies in 2025. Trend: 2023 $966 · 2024 $1,458 · 2025 $1,371
Food & beverage: $1,371
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $194 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $177 |
| Abbott Laboratories | 2 | $165 |
| SCPHARMACEUTICALS INC. | 7 | $162 |
| Alnylam Pharmaceuticals Inc. | 3 | $132 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $107 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| PFIZER INC. | 2 | $49 |
| Lilly USA, LLC | 2 | $38 |
Products named: LEQVIO, JARDIANCE, CARDIOMEMS, FUROSCIX, Kerendia, ELIQUIS, AMVUTTRA, VERQUVO.
Industry payments across MI — which companies pay providers there.
